双威布尔ROC曲线下面积估计方法的比较。

IF 1.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY
Ruhul Ali Khan, Musie Ghebremichael
{"title":"双威布尔ROC曲线下面积估计方法的比较。","authors":"Ruhul Ali Khan, Musie Ghebremichael","doi":"10.1002/pst.70038","DOIUrl":null,"url":null,"abstract":"<p><p>In this paper, we carried out extensive simulation studies to compare the performances of partial and maximum likelihood based methods for estimating the area under the bi-Weibull ROC curve. Further, real data sets from HIV/AIDS research were analyzed for illustrative purposes. Simulation results suggest that both methods perform well and yield similar results for Weibull data. However, for non-Weibull data, both methods perform poorly. The bi-Weibull model yields smooth estimates of ROC curves and a closed-form expression for the area under the ROC curve. Moreover, by adjusting its shape parameter, the bi-Weibull model can represent a variety of distributions, such as exponential, Rayleigh, normal, and extreme value distributions. Its compatibility with Cox's proportional hazards model facilitates the derivation of covariate-adjusted ROC curves and supports analyses involving correlated and longitudinal biomarkers. These properties make the model very useful in the ROC curve analyses. Thus, the bi-Weibull model should be considered as an alternative when the restrictive distributional assumptions of the commonly used parametric models (e.g., binormal model) are not met.</p>","PeriodicalId":19934,"journal":{"name":"Pharmaceutical Statistics","volume":"24 5","pages":"e70038"},"PeriodicalIF":1.4000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparing Estimation Methods for the Area Under the Bi-Weibull ROC Curve.\",\"authors\":\"Ruhul Ali Khan, Musie Ghebremichael\",\"doi\":\"10.1002/pst.70038\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In this paper, we carried out extensive simulation studies to compare the performances of partial and maximum likelihood based methods for estimating the area under the bi-Weibull ROC curve. Further, real data sets from HIV/AIDS research were analyzed for illustrative purposes. Simulation results suggest that both methods perform well and yield similar results for Weibull data. However, for non-Weibull data, both methods perform poorly. The bi-Weibull model yields smooth estimates of ROC curves and a closed-form expression for the area under the ROC curve. Moreover, by adjusting its shape parameter, the bi-Weibull model can represent a variety of distributions, such as exponential, Rayleigh, normal, and extreme value distributions. Its compatibility with Cox's proportional hazards model facilitates the derivation of covariate-adjusted ROC curves and supports analyses involving correlated and longitudinal biomarkers. These properties make the model very useful in the ROC curve analyses. Thus, the bi-Weibull model should be considered as an alternative when the restrictive distributional assumptions of the commonly used parametric models (e.g., binormal model) are not met.</p>\",\"PeriodicalId\":19934,\"journal\":{\"name\":\"Pharmaceutical Statistics\",\"volume\":\"24 5\",\"pages\":\"e70038\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmaceutical Statistics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/pst.70038\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Statistics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/pst.70038","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

在本文中,我们进行了广泛的仿真研究,以比较基于部分似然和最大似然的方法在估计双威布尔ROC曲线下面积方面的性能。此外,为了说明问题,还分析了来自艾滋病毒/艾滋病研究的真实数据集。仿真结果表明,两种方法对威布尔数据的处理效果良好,且结果相似。然而,对于非威布尔数据,这两种方法的性能都很差。双威布尔模型产生ROC曲线的平滑估计和ROC曲线下面积的封闭形式表达式。此外,通过调整其形状参数,双威布尔模型可以表示各种分布,如指数分布、瑞利分布、正态分布和极值分布。它与Cox比例风险模型的兼容性有利于协变量校正ROC曲线的推导,并支持涉及相关和纵向生物标志物的分析。这些特性使该模型在ROC曲线分析中非常有用。因此,当常用参数模型(如二正态模型)的限制性分布假设不满足时,应考虑采用双威布尔模型。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Comparing Estimation Methods for the Area Under the Bi-Weibull ROC Curve.

In this paper, we carried out extensive simulation studies to compare the performances of partial and maximum likelihood based methods for estimating the area under the bi-Weibull ROC curve. Further, real data sets from HIV/AIDS research were analyzed for illustrative purposes. Simulation results suggest that both methods perform well and yield similar results for Weibull data. However, for non-Weibull data, both methods perform poorly. The bi-Weibull model yields smooth estimates of ROC curves and a closed-form expression for the area under the ROC curve. Moreover, by adjusting its shape parameter, the bi-Weibull model can represent a variety of distributions, such as exponential, Rayleigh, normal, and extreme value distributions. Its compatibility with Cox's proportional hazards model facilitates the derivation of covariate-adjusted ROC curves and supports analyses involving correlated and longitudinal biomarkers. These properties make the model very useful in the ROC curve analyses. Thus, the bi-Weibull model should be considered as an alternative when the restrictive distributional assumptions of the commonly used parametric models (e.g., binormal model) are not met.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Pharmaceutical Statistics
Pharmaceutical Statistics 医学-统计学与概率论
CiteScore
2.70
自引率
6.70%
发文量
90
审稿时长
6-12 weeks
期刊介绍: Pharmaceutical Statistics is an industry-led initiative, tackling real problems in statistical applications. The Journal publishes papers that share experiences in the practical application of statistics within the pharmaceutical industry. It covers all aspects of pharmaceutical statistical applications from discovery, through pre-clinical development, clinical development, post-marketing surveillance, consumer health, production, epidemiology, and health economics. The Journal is both international and multidisciplinary. It includes high quality practical papers, case studies and review papers.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信